PLRX Q4 2024 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$85M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$53M

Net Income

-$50M

EPS (Diluted)

$-0.82

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$48M

Free Cash Flow

-$48M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$397M

Total Liabilities

$93M

Stockholders' Equity

$304M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$53M	-$47M	-13.4%
Net Income	-$50M	-$41M	-21.0%